Drug
Lbl 034 For
Lbl 034 For: highest development phase Phase 1/2, developed by Nanjing Leads Biolabs Co.,Ltd. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Nanjing Leads Biolabs Co.,Ltd
Trials
| Drug | Phase | Indication |
|---|---|---|
| LBL-034 for Injection NCT06049290 | Phase 1/2 | Relapsed/Refractory Multiple Myeloma |
Latest
No recent events.
Follow Lbl 034 For on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.